Aurinia Pharmaceuticals Inc. (AUPH) vs Mineralys Therapeutics, Inc. (MLYS)

A side-by-side comparison of Aurinia Pharmaceuticals Inc. and Mineralys Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare
Aurinia Pharmaceuticals Inc. logo
AUPH
Aurinia Pharmaceuticals Inc.
$2.02B
$15.72HealthcareDelayed quote: Oct 6, 2026, 12:10 PM EDT
Mineralys Therapeutics, Inc. logo
MLYS
Mineralys Therapeutics, Inc.
$2.01B
$22.75HealthcareDelayed quote: Oct 6, 2026, 12:10 PM EDT

Total return — AUPH vs MLYS

growth of $100 · dividends reinvested · last 4y
AUPH +85.4% (+16.7%/yr)MLYS +26.4% (+6.0%/yr)AUPH compounded faster over this window
50100150200250Start $100202420252026$185$126
AUPH MLYS

AUPH vs MLYS: by the numbers

  • •AUPH is the larger company ($2.02B vs $2.01B market cap).
  • •AUPH is profitable (100.84% net margin) while MLYS runs a net loss (0.00%).

Metrics side by side

Valuation

MetricAUPHMLYS
P/E ratio6.86N/A
Forward P/E16.65N/A
P/S ratio6.49N/A
P/B ratio3.293.64
EV / EBITDA11.18N/A
FCF yield8.59%N/A

Profitability

MetricAUPHMLYS
Gross margin90.36%0.00%
Operating margin37.06%0.00%
Net margin100.84%0.00%
ROE51.09%-63.45%
ROIC21.77%-57.17%

Growth (annualized)

MetricAUPHMLYS
Revenue CAGR (5Y)40.17%N/A
Total return CAGR (5Y)-5.88%N/A

Frequently asked

Is AUPH or MLYS more profitable?
AUPH runs the higher net margin — AUPH at 100.84% versus MLYS at 0.00%.

Go deeper

Full AUPH analysisFull MLYS analysisInteractive comparison tool

Dig into the metrics

Aurinia Pharmaceuticals P/E ratioAurinia Pharmaceuticals ROEMineralys Therapeutics ROEAurinia Pharmaceuticals operating marginMineralys Therapeutics operating marginAurinia Pharmaceuticals revenue growthMineralys Therapeutics revenue growthAurinia Pharmaceuticals free cash flowMineralys Therapeutics free cash flow

Aurinia Pharmaceuticals & Mineralys Therapeutics appear in these rankings

Fastest Revenue Growth StocksHighest ROE StocksHighest ROIC StocksHighest Operating Margin Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.